nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—MTNR1B—metabolic syndrome X	0.729	0.796	CbGaD
Agomelatine—HTR2C—metabolic syndrome X	0.186	0.203	CbGaD
Agomelatine—Melatonin—MTNR1B—metabolic syndrome X	0.00189	0.374	CrCbGaD
Agomelatine—Indomethacin—PPARA—metabolic syndrome X	0.0011	0.218	CrCbGaD
Agomelatine—Nabumetone—PTGS2—metabolic syndrome X	0.000593	0.117	CrCbGaD
Agomelatine—Migraine—Metformin—metabolic syndrome X	0.000545	0.0592	CcSEcCtD
Agomelatine—Indomethacin—PPARG—metabolic syndrome X	0.000526	0.104	CrCbGaD
Agomelatine—Nasopharyngitis—Metformin—metabolic syndrome X	0.000495	0.0538	CcSEcCtD
Agomelatine—Influenza—Metformin—metabolic syndrome X	0.000479	0.052	CcSEcCtD
Agomelatine—Infestation NOS—Metformin—metabolic syndrome X	0.000427	0.0463	CcSEcCtD
Agomelatine—Infestation—Metformin—metabolic syndrome X	0.000427	0.0463	CcSEcCtD
Agomelatine—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000404	0.0438	CcSEcCtD
Agomelatine—Hepatitis—Metformin—metabolic syndrome X	0.000383	0.0416	CcSEcCtD
Agomelatine—Connective tissue disorder—Metformin—metabolic syndrome X	0.000377	0.0409	CcSEcCtD
Agomelatine—Eye disorder—Metformin—metabolic syndrome X	0.000358	0.0389	CcSEcCtD
Agomelatine—Vision blurred—Metformin—metabolic syndrome X	0.000314	0.0341	CcSEcCtD
Agomelatine—Tremor—Metformin—metabolic syndrome X	0.000313	0.0339	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000282	0.0306	CcSEcCtD
Agomelatine—Naproxen—PTGS2—metabolic syndrome X	0.000274	0.0543	CrCbGaD
Agomelatine—Infection—Metformin—metabolic syndrome X	0.000271	0.0294	CcSEcCtD
Agomelatine—Nervous system disorder—Metformin—metabolic syndrome X	0.000267	0.029	CcSEcCtD
Agomelatine—Skin disorder—Metformin—metabolic syndrome X	0.000264	0.0287	CcSEcCtD
Agomelatine—Hyperhidrosis—Metformin—metabolic syndrome X	0.000263	0.0286	CcSEcCtD
Agomelatine—Paraesthesia—Metformin—metabolic syndrome X	0.000245	0.0265	CcSEcCtD
Agomelatine—Naproxen—ALB—metabolic syndrome X	0.000244	0.0484	CrCbGaD
Agomelatine—Somnolence—Metformin—metabolic syndrome X	0.000242	0.0263	CcSEcCtD
Agomelatine—Dyspepsia—Metformin—metabolic syndrome X	0.00024	0.026	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000235	0.0255	CcSEcCtD
Agomelatine—Fatigue—Metformin—metabolic syndrome X	0.000235	0.0255	CcSEcCtD
Agomelatine—Constipation—Metformin—metabolic syndrome X	0.000233	0.0253	CcSEcCtD
Agomelatine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000223	0.0242	CcSEcCtD
Agomelatine—Indomethacin—PTGS2—metabolic syndrome X	0.000222	0.044	CrCbGaD
Agomelatine—Urticaria—Metformin—metabolic syndrome X	0.000216	0.0235	CcSEcCtD
Agomelatine—Abdominal pain—Metformin—metabolic syndrome X	0.000215	0.0234	CcSEcCtD
Agomelatine—Indomethacin—ALB—metabolic syndrome X	0.000198	0.0392	CrCbGaD
Agomelatine—Asthenia—Metformin—metabolic syndrome X	0.000195	0.0212	CcSEcCtD
Agomelatine—Pruritus—Metformin—metabolic syndrome X	0.000193	0.0209	CcSEcCtD
Agomelatine—Diarrhoea—Metformin—metabolic syndrome X	0.000186	0.0202	CcSEcCtD
Agomelatine—Dizziness—Metformin—metabolic syndrome X	0.00018	0.0195	CcSEcCtD
Agomelatine—Vomiting—Metformin—metabolic syndrome X	0.000173	0.0188	CcSEcCtD
Agomelatine—Headache—Metformin—metabolic syndrome X	0.000171	0.0185	CcSEcCtD
Agomelatine—Nausea—Metformin—metabolic syndrome X	0.000162	0.0176	CcSEcCtD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	4.96e-05	0.000705	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AGT—metabolic syndrome X	4.9e-05	0.000696	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AGT—metabolic syndrome X	4.9e-05	0.000696	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—GHRL—metabolic syndrome X	4.8e-05	0.000682	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—LEP—metabolic syndrome X	4.8e-05	0.000682	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—LEP—metabolic syndrome X	4.8e-05	0.000682	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—APOE—metabolic syndrome X	4.8e-05	0.000682	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—APOE—metabolic syndrome X	4.8e-05	0.000682	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MTNR1B—metabolic syndrome X	4.76e-05	0.000677	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—APOA1—metabolic syndrome X	4.75e-05	0.000674	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—APOA1—metabolic syndrome X	4.75e-05	0.000674	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2C—metabolic syndrome X	4.6e-05	0.000654	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	4.55e-05	0.000647	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CNR1—metabolic syndrome X	4.55e-05	0.000646	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	4.47e-05	0.000635	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—GHRL—metabolic syndrome X	4.36e-05	0.00062	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	4.32e-05	0.000613	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCL2—metabolic syndrome X	4.3e-05	0.000611	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IRS1—metabolic syndrome X	4.28e-05	0.000609	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IRS1—metabolic syndrome X	4.28e-05	0.000609	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	4.24e-05	0.000602	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	4.22e-05	0.000599	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AGT—metabolic syndrome X	4.21e-05	0.000598	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CNR1—metabolic syndrome X	4.13e-05	0.000587	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—INS—metabolic syndrome X	4.1e-05	0.000583	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—INS—metabolic syndrome X	4.1e-05	0.000583	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	4.08e-05	0.00058	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	4.04e-05	0.000574	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL2—metabolic syndrome X	4.04e-05	0.000573	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL2—metabolic syndrome X	4.04e-05	0.000573	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IGF1—metabolic syndrome X	3.97e-05	0.000564	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IGF1—metabolic syndrome X	3.97e-05	0.000564	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HDAC3—metabolic syndrome X	3.9e-05	0.000554	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GHRL—metabolic syndrome X	3.88e-05	0.000551	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	3.77e-05	0.000535	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SERPINE1—metabolic syndrome X	3.77e-05	0.000535	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	3.76e-05	0.000534	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	3.69e-05	0.000524	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CNR1—metabolic syndrome X	3.67e-05	0.000521	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	3.6e-05	0.000512	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOS3—metabolic syndrome X	3.6e-05	0.000511	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOS3—metabolic syndrome X	3.6e-05	0.000511	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCL5—metabolic syndrome X	3.53e-05	0.000501	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GHRL—metabolic syndrome X	3.52e-05	0.0005	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	3.49e-05	0.000496	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MTNR1B—metabolic syndrome X	3.49e-05	0.000496	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL2—metabolic syndrome X	3.47e-05	0.000493	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	3.46e-05	0.000491	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RBP4—metabolic syndrome X	3.4e-05	0.000483	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TRIB3—metabolic syndrome X	3.4e-05	0.000483	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	3.39e-05	0.000481	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	3.35e-05	0.000476	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CNR1—metabolic syndrome X	3.33e-05	0.000473	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	3.33e-05	0.000473	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FMO3—metabolic syndrome X	3.27e-05	0.000465	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	3.23e-05	0.000459	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	3.21e-05	0.000456	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL5—metabolic syndrome X	3.2e-05	0.000455	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	3.19e-05	0.000453	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HDAC3—metabolic syndrome X	3.15e-05	0.000447	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	3.1e-05	0.00044	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.08e-05	0.000438	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	3.08e-05	0.000438	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—metabolic syndrome X	3.03e-05	0.000431	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—metabolic syndrome X	3.03e-05	0.000431	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOC3—metabolic syndrome X	3.01e-05	0.000428	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	3.01e-05	0.000427	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGT—metabolic syndrome X	2.95e-05	0.000419	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	2.92e-05	0.000415	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	2.92e-05	0.000414	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	2.92e-05	0.000414	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	2.86e-05	0.000407	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	2.85e-05	0.000404	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCL5—metabolic syndrome X	2.84e-05	0.000404	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MTNR1B—metabolic syndrome X	2.81e-05	0.0004	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AKT1—metabolic syndrome X	2.8e-05	0.000398	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AKT1—metabolic syndrome X	2.8e-05	0.000398	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FMO3—metabolic syndrome X	2.79e-05	0.000397	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	2.76e-05	0.000392	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TRIB3—metabolic syndrome X	2.74e-05	0.00039	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RBP4—metabolic syndrome X	2.74e-05	0.00039	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	2.74e-05	0.000389	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	2.73e-05	0.000388	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2C—metabolic syndrome X	2.72e-05	0.000386	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGT—metabolic syndrome X	2.68e-05	0.00038	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	2.65e-05	0.000376	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CYBA—metabolic syndrome X	2.63e-05	0.000374	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.61e-05	0.00037	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL5—metabolic syndrome X	2.58e-05	0.000367	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GHRL—metabolic syndrome X	2.58e-05	0.000366	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.57e-05	0.000366	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	2.57e-05	0.000365	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.52e-05	0.000359	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	2.5e-05	0.000355	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	2.49e-05	0.000354	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	2.49e-05	0.000354	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CNR1—metabolic syndrome X	2.44e-05	0.000347	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOC3—metabolic syndrome X	2.43e-05	0.000345	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGT—metabolic syndrome X	2.38e-05	0.000338	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFB1—metabolic syndrome X	2.38e-05	0.000338	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFB1—metabolic syndrome X	2.38e-05	0.000338	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	2.34e-05	0.000333	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FABP4—metabolic syndrome X	2.33e-05	0.000331	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.23e-05	0.000316	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	2.21e-05	0.000314	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL2—metabolic syndrome X	2.21e-05	0.000313	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGT—metabolic syndrome X	2.16e-05	0.000307	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.16e-05	0.000306	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.14e-05	0.000304	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CYBA—metabolic syndrome X	2.12e-05	0.000302	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.08e-05	0.000296	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GHRL—metabolic syndrome X	2.08e-05	0.000295	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.04e-05	0.00029	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF2—metabolic syndrome X	2e-05	0.000283	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FABP4—metabolic syndrome X	1.99e-05	0.000283	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—G6PD—metabolic syndrome X	1.97e-05	0.00028	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CNR1—metabolic syndrome X	1.97e-05	0.00028	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.94e-05	0.000276	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOB—metabolic syndrome X	1.94e-05	0.000275	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	1.92e-05	0.000273	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL5—metabolic syndrome X	1.89e-05	0.000269	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	1.89e-05	0.000268	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.88e-05	0.000268	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPA—metabolic syndrome X	1.88e-05	0.000267	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCKR—metabolic syndrome X	1.88e-05	0.000267	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LPL—metabolic syndrome X	1.85e-05	0.000263	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.83e-05	0.00026	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	1.82e-05	0.000258	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.81e-05	0.000257	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA5—metabolic syndrome X	1.8e-05	0.000256	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—metabolic syndrome X	1.79e-05	0.000255	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—metabolic syndrome X	1.79e-05	0.000255	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.78e-05	0.000253	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL2—metabolic syndrome X	1.78e-05	0.000253	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.75e-05	0.000249	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.75e-05	0.000248	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.71e-05	0.000243	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.69e-05	0.000241	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—G6PD—metabolic syndrome X	1.68e-05	0.000239	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	1.67e-05	0.000238	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.66e-05	0.000236	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—metabolic syndrome X	1.65e-05	0.000235	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—metabolic syndrome X	1.65e-05	0.000235	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	1.64e-05	0.000233	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF2—metabolic syndrome X	1.61e-05	0.000229	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPA—metabolic syndrome X	1.61e-05	0.000228	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCKR—metabolic syndrome X	1.61e-05	0.000228	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGT—metabolic syndrome X	1.58e-05	0.000225	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOB—metabolic syndrome X	1.56e-05	0.000222	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	1.55e-05	0.000221	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LEP—metabolic syndrome X	1.55e-05	0.00022	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—metabolic syndrome X	1.55e-05	0.00022	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.54e-05	0.000219	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA5—metabolic syndrome X	1.54e-05	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOA1—metabolic syndrome X	1.53e-05	0.000218	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL5—metabolic syndrome X	1.53e-05	0.000217	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.52e-05	0.000216	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	1.5e-05	0.000213	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.49e-05	0.000212	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.49e-05	0.000212	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LIPC—metabolic syndrome X	1.49e-05	0.000212	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCK—metabolic syndrome X	1.49e-05	0.000212	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LPL—metabolic syndrome X	1.49e-05	0.000212	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOC3—metabolic syndrome X	1.48e-05	0.000211	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.46e-05	0.000208	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.45e-05	0.000206	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CETP—metabolic syndrome X	1.44e-05	0.000205	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	1.43e-05	0.000203	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IRS1—metabolic syndrome X	1.38e-05	0.000196	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	1.38e-05	0.000196	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.34e-05	0.000191	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	1.34e-05	0.00019	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INS—metabolic syndrome X	1.32e-05	0.000188	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL2—metabolic syndrome X	1.3e-05	0.000185	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	1.3e-05	0.000185	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GOT2—metabolic syndrome X	1.3e-05	0.000185	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	1.28e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1—metabolic syndrome X	1.28e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.28e-05	0.000181	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.28e-05	0.000181	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LIPC—metabolic syndrome X	1.28e-05	0.000181	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCK—metabolic syndrome X	1.28e-05	0.000181	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOC3—metabolic syndrome X	1.27e-05	0.00018	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.25e-05	0.000178	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.25e-05	0.000178	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.24e-05	0.000176	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CETP—metabolic syndrome X	1.23e-05	0.000175	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.22e-05	0.000173	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	1.18e-05	0.000167	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.17e-05	0.000167	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	1.16e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	1.16e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	1.16e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.15e-05	0.000163	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.14e-05	0.000162	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GGT1—metabolic syndrome X	1.12e-05	0.00016	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GOT1—metabolic syndrome X	1.12e-05	0.00016	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.12e-05	0.000158	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.11e-05	0.000158	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.11e-05	0.000158	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.07e-05	0.000152	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.03e-05	0.000147	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1e-05	0.000143	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.95e-06	0.000141	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	9.92e-06	0.000141	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	9.92e-06	0.000141	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	9.81e-06	0.000139	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	9.8e-06	0.000139	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	9.6e-06	0.000136	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	9.6e-06	0.000136	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOB—metabolic syndrome X	9.54e-06	0.000135	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	9.37e-06	0.000133	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	9.28e-06	0.000132	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPL—metabolic syndrome X	9.11e-06	0.000129	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	9.04e-06	0.000128	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CD36—metabolic syndrome X	8.65e-06	0.000123	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOB—metabolic syndrome X	8.15e-06	0.000116	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARA—metabolic syndrome X	8.04e-06	0.000114	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.03e-06	0.000114	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	7.93e-06	0.000113	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	7.9e-06	0.000112	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGT—metabolic syndrome X	7.79e-06	0.000111	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPL—metabolic syndrome X	7.78e-06	0.000111	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	7.68e-06	0.000109	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—metabolic syndrome X	7.63e-06	0.000108	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA1—metabolic syndrome X	7.55e-06	0.000107	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.39e-06	0.000105	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.29e-06	0.000104	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	6.87e-06	9.77e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGT—metabolic syndrome X	6.66e-06	9.46e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARG—metabolic syndrome X	6.65e-06	9.45e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—metabolic syndrome X	6.52e-06	9.27e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INS—metabolic syndrome X	6.52e-06	9.26e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.45e-06	9.16e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.2e-06	8.8e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—metabolic syndrome X	5.98e-06	8.49e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	5.79e-06	8.22e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—metabolic syndrome X	5.72e-06	8.12e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	5.68e-06	8.07e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INS—metabolic syndrome X	5.57e-06	7.92e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	5.34e-06	7.58e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	5.23e-06	7.43e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—metabolic syndrome X	5.11e-06	7.26e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	4.89e-06	6.94e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.67e-06	6.63e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.47e-06	6.35e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.31e-06	6.12e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.63e-06	3.73e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.25e-06	3.19e-05	CbGpPWpGaD
